Sofosbuvir for treating chronic hepatitis C

Review proposal consultation

Draft matrix of consultees and commentators post referral (PDF 269 KB)

Review proposal paper (PDF 537 KB)

Final appraisal determination

Committee papers (PDF 10.11 MB)

Final appraisal determination document (PDF 763 KB)

Hepatitis C (chronic) - sofosbuvir: equality impact assessment (PDF 194 KB)

Hepatitis C (chronic) - sofosbuvir: appraisal consultation 2

Hepatitis C (chronic) - sofosbuvir: consultation document information

Hepatitis C (chronic) - sofosbuvir: evaluation report information

Hepatitis C (chronic) - sofosbuvir: evaluation report (PDF 4.97 MB)

Hepatitis C (chronic) - sofosbuvir: appraisal consultation

Hepatitis C (chronic) - sofosbuvir: appraisal consultation document information

Hepatitis C (chronic) - sofosbuvir: evaluation report information

Hepatitis C (chronic) - sofosbuvir: evaluation report (PDF 10.52 MB)

Hepatitis C (chronic) - sofosbuvir: equality impact assessment - scoping (PDF 63 KB)

Hepatitis C (chronic) - sofosbuvir: final scope (PDF 103 KB)

Hepatitis C (chronic) - sofosbuvir: final matrix (PDF 102 KB)

Hepatitis C (chronic) - sofosbuvir: response to consultee and commentator comments on the draft scope and provisional matrix (PDF 512 KB)

Hepatitis C (chronic) - sofosbuvir: appendix B - draft scope for consultation (pre-referral) - June 2013 (PDF 70 KB)

Hepatitis C (chronic) - sofosbuvir: appendix C - provisional matrix (pre-referral) - June 2013 (PDF 64 KB)